{"DataElement":{"publicId":"7124841","version":"1","preferredName":"Tumor Segment Non-Cellular Component Text","preferredDefinition":"A free text field documenting the non-cellular component (includes cytokines, chemokines, complements, and other mediators of inflammation, to the non-cellular component of blood (plasma), or the non-cellular component of body fluids and broncoalveolar lavage fluid) in the tumor segment.","longName":"7119784v1.0:6847557v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7119784","version":"1","preferredName":"Tumor Segment Non-Cellular Component","preferredDefinition":"Sufficient total material from each patient, divided to yield a minimum of one aliquot, preferably divided into three to five aliquots, of specified cancer tissue suitable for processing for proteomic and genomic analysis._A term that refers to the non-cellular component of the innate immune system which includes cytokines, chemokines, complements, and other mediators of inflammation, to the non-cellular component of blood (plasma), or the non-cellular component of body fluids and broncoalveolar lavage fluid.","longName":"7119487v1.0:7119782v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7119487","version":"1","preferredName":"Tumor Segment","preferredDefinition":"Sufficient total material from each patient, divided to yield a minimum of one aliquot, preferably divided into three to five aliquots, of specified cancer tissue suitable for processing for proteomic and genomic analysis.","longName":"C162622","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Segment","conceptCode":"C162622","definition":"Sufficient total material from each patient, divided to yield a minimum of one aliquot, preferably divided into three to five aliquots, of specified cancer tissue suitable for processing for proteomic and genomic analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9B7C823A-3A71-01FE-E053-F662850AC3D6","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-06","modifiedBy":"ONEDATA","dateModified":"2020-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7119782","version":"1","preferredName":"Non-Cellular Component","preferredDefinition":"A term that refers to the non-cellular component of the innate immune system which includes cytokines, chemokines, complements, and other mediators of inflammation, to the non-cellular component of blood (plasma), or the non-cellular component of body fluids and broncoalveolar lavage fluid.","longName":"C125905","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Cellular Component","conceptCode":"C125905","definition":"A term that refers to the non-cellular component of the innate immune system which includes cytokines, chemokines, complements, and other mediators of inflammation, to the non-cellular component of blood (plasma), or the non-cellular component of body fluids and broncoalveolar lavage fluid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9B7CF101-6059-020A-E053-F662850AF630","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-06","modifiedBy":"ONEDATA","dateModified":"2020-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435029","version":"1","preferredName":"Molecular Abnormality","preferredDefinition":"Abnormalities that occur in human cells and tissues and models of human cancer.","longName":"C3910","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432BB3-787B-25DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9B7CF101-606A-020A-E053-F662850AF630","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-06","modifiedBy":"KNABLEJ","dateModified":"2020-02-13","changeDescription":"1/22/20 jk released per CPTAC SME's review of PRAD Path Review CDE set. 1/6/20 jk created for CPTAC Path Review CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6847557","version":"1","preferredName":"4000 Character Text","preferredDefinition":"The words of something written.","longName":"6847557v1.0","context":"OCCPR","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"4000","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8F78F00C-3668-5BB9-E053-F662850A122E","latestVersionIndicator":"Yes","beginDate":"2019-08-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-08-06","modifiedBy":"KNABLEJ","dateModified":"2020-02-12","changeDescription":"1/2/20 jk Released per CPTAC SME (Linda) for PRAD Baseline CRF.  8/6/19 jk created for multiple CPTAC CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"5635361","version":"1","longName":"Bladder","context":"OCCPR"},{"publicId":"6779607","version":"1","longName":"BLCA Local Pathology","context":"OCCPR"},{"publicId":"6779608","version":"1","longName":"BLCA Pathology Review","context":"OCCPR"},{"publicId":"6570064","version":"1","longName":"Stomach","context":"OCCPR"},{"publicId":"6779567","version":"1","longName":"STAD Local Pathology","context":"OCCPR"},{"publicId":"6779568","version":"1","longName":"STAD Pathology Review","context":"OCCPR"},{"publicId":"10000439","version":"1","longName":"Thyroid","context":"OCCPR"},{"publicId":"6779572","version":"1","longName":"THCA Local Pathology","context":"OCCPR"},{"publicId":"6779573","version":"1","longName":"THCA Pathology Review","context":"OCCPR"},{"publicId":"6776735","version":"1","longName":"Eye","context":"OCCPR"},{"publicId":"6779575","version":"1","longName":"UVM Local Pathology","context":"OCCPR"},{"publicId":"6779576","version":"1","longName":"UVM Pathology Review","context":"OCCPR"},{"publicId":"6570063","version":"1","longName":"Cervix","context":"OCCPR"},{"publicId":"6779610","version":"1","longName":"CESC Local Pathology","context":"OCCPR"},{"publicId":"6779611","version":"1","longName":"CESC Pathology Review","context":"OCCPR"},{"publicId":"6776762","version":"1","longName":"Bile duct and Liver","context":"OCCPR"},{"publicId":"6779539","version":"1","longName":"CHOL Local Pathology","context":"OCCPR"},{"publicId":"6779540","version":"1","longName":"CHOL Pathology Review","context":"OCCPR"},{"publicId":"6779542","version":"1","longName":"LIHC Local Pathology","context":"OCCPR"},{"publicId":"6779543","version":"1","longName":"LIHC Pathology Review","context":"OCCPR"},{"publicId":"6601282","version":"1","longName":"Esophagus","context":"OCCPR"},{"publicId":"6779554","version":"1","longName":"ESCA Local Pathology","context":"OCCPR"},{"publicId":"6779555","version":"1","longName":"ESCA Pathology Review","context":"OCCPR"},{"publicId":"5635376","version":"1","longName":"Prostate","context":"OCCPR"},{"publicId":"6779562","version":"1","longName":"PRAD Local Pathology","context":"OCCPR"},{"publicId":"6779563","version":"1","longName":"PRAD Pathology Review","context":"OCCPR"},{"publicId":"6601275","version":"1","longName":"Brain","context":"OCCPR"},{"publicId":"6779545","version":"1","longName":"LGG Local Pathology","context":"OCCPR"},{"publicId":"6779546","version":"1","longName":"LGG Pathology Review","context":"OCCPR"},{"publicId":"10000348","version":"1","longName":"Melanoma","context":"OCCPR"},{"publicId":"7639000","version":"1","longName":"CM Pathology Review","context":"OCCPR"},{"publicId":"7218867","version":"1","longName":"Head and Neck","context":"OCCPR"},{"publicId":"7634287","version":"1","longName":"HNSCC Pathology Review","context":"OCCPR"},{"publicId":"7638999","version":"1","longName":"HNSCC Local Pathology","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Describe non-cellular compone","type":"Preferred Question Text","description":"Describe non-cellular component","url":null,"context":"OCCPR"},{"name":"CPTAC-PATH-1","type":"Alternate Question Text","description":"FFPE QC:  Block ID (QC cassette ID) of the sample from which this slide was derived","url":null,"context":"OCCPR"},{"name":"CPTAC-1","type":"Coding Instructions","description":"Identifiers are in format of C3Y-XXXXX- ZZ where Y is either N for NCI or L for Leidos, XXXXX is the case ID/kit id, ZZ equals the type of specimen.  There is a  pre-defined list of specimen types for CPTAC specimens.","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9B955A0B-7507-3DA0-E053-F662850AECD3","latestVersionIndicator":"Yes","beginDate":"2020-01-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-07","modifiedBy":"COLBERTM","dateModified":"2022-09-11","changeDescription":"8/17/21 jk added CM Path Rpt CSI. 7/12/21 jk added HNSCC Path Rpt CSI. 4/30/20 jk added CPTAC LGG Path CSI. 1/22/20 jk released per CPTAC SME's review of PRAD Path Review CDE set. 1/7/20 jk created for CPTAC Path Review and Local Path CRFs; applicable to all tumor types.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}